June 8, 2022
National Center for Global Health and Medicine《Event Information》
ARISE-PMDA Joint symposium for
Asian Clinical Trial"How to promote clinical trials in Asia to enable earlypatient access for pharmaceutical products."

Date and Time： July 12, 2022, 15:00 to 18:00（Japan time）
Event Type： Webinar（Zoom）
Registration Fee： Free（Pre-registration is required）

National Center for Global Health and Medicine (NCGM) and Pharmaceuticals and Medical
Devices Agency (PMDA) will hold the "ARISE-PMDA Joint symposium for Asian Clinical Trial"How to promote clinical trials in Asia to enable early patient access to pharmaceuticalproducts" from 15:00 to 18:00 on Tuesday, July 12.
◇Since 2020, NCGM has been supported by the "Project for Establishment of Network ofClinical Research and Clinical Trials in Asia" of the Japan Agency for Medical Research andDevelopment (AMED). Furthermore, NCGM has established the ARO Alliance for ASEAN andEast Asia (hereinafter ARISE) to promote global clinical trials in Asia and launched ARISE inDecember 2021. Cooperation with regulatory authorities as well as academia in each country
is essential to conduct high-quality multi-regional clinical trials in compliance with regulationsin Asia and accelerate regulatory approvals. Therefore, this symposium will be held jointly withPMDA, promoting regulatory harmonization in Asia.
◇In the first session, NCGM will introduce the role of ARISE in promoting clinical trials in Asia.
In the second session, presentations will be given on "Promotion of Good Clinical Practice(GCP) in Asia," including presentations on initiatives by regulatory authorities in Asia andexpectations of Japanese pharmaceutical companies.
In the third session, under the theme of "How to combat COVID-19," presentations will begiven on initiatives for early patient access to COVID-19 pharmaceuticals by industry,
government, and academia, followed by a panel discussion among Japanese and Asian experts
in various fields.
This symposium will be a valuable opportunity to understand the main points of eachcountry's pharmaceutical regulations to promote clinical trials in Asia and discuss early patient
access to COVID-19 vaccines and therapeutics.
Anyone can participate for free. If you would like to attend the symposium, please registerin advance on the website.
The overview of the ARISE-PMDA Joint symposium for Asian Clinical Trial is as follows.
1

ARISE-PMDA Joint symposium for
Asian Clinical Trial"How to promote clinical trials in Asia to enable early patient
access for pharmaceutical products."

Date and Time： July 12, 2022, 15:00 to 18:00（Japan time）
Event Type： Webinar（Zoom）
Language: Simultaneous Interpretation （Japanese and English）
Co-organized： National Center for Global Health and Medicine (NCGM),
Pharmaceuticals and Medical Devices Agency (PMDA)
Sponsors： ARISE Member Institutes,
Japan Agency for Medical Research Department (AMED),Japan Pharmaceutical Manufacturers Association (JPMA)
For more information or registration, please go to the link below.
https:///event-info.jp/NCGM/event/arise_symposium/
Registration deadline: July 11 2022 at 18:00 in Japan Time★Contact information for the event

ARISE_PMDA Clinical Research Symposium Secretariat
Hour: Monday ‒ Friday, 10:00 a.m. - 6:00 p.m.
E-mail: arise_symposium@event-info.jp★Contact information for the organizer

Department of International Trials
Center for Clinical Sciences
National Center for Global Health and Medicine
1-21-1, Toyama, Shinjuku, Tokyo 162-8655 JAPANTel : +81-3-6228-0445
E-mail: dit-info@hosp.ncgm.go.jp

2